Abstract:Through the combined use of (18)F-fallypride positron emission tomography and magnetic resonance imaging this study examined the neural mechanisms underlying the attentional deficits associated with attention deficit/hyperactivity disorder and their potential reversal with a single therapeutic dose of methylphenidate. Sixteen adult patients with attention deficit/hyperactivity disorder and 16 matched healthy control subjects were positron emission tomography and magnetic resonance imaging scanned and tested on a computerized sustained attention task after oral methylphenidate (0.5 mg/kg) and placebo administration in a within-subject, double-blind, cross-over design. Although patients with attention deficit/hyperactivity disorder as a group showed significant attentional deficits and reduced grey matter volume in fronto-striato-cerebellar and limbic networks, they had equivalent D2/D3 receptor availability and equivalent increases in endogenous dopamine after methylphenidate treatment to that observed in healthy control subjects. However, poor attentional performers drawn from both the attention deficit/hyperactivity disorder and the control groups had significantly reduced left caudate dopamine activity. Methylphenidate significantly increased dopamine levels in all nigro-striatal regions, thereby normalizing dopamine levels in the left caudate in low performers. Behaviourally, methylphenidate improved sustained attention in a baseline performance-dependent manner, irrespective of diagnosis. This finding was accompanied by an equally performance-dependent effect of the drug on dopamine release in the midbrain, whereby low performers showed reduced dopamine release in this region. Collectively, these findings support a dimensional model of attentional deficits and underlying nigro-striatal dopaminergic mechanisms of attention deficit/hyperactivity disorder that extends into the healthy population. Moreover, they confer midbrain dopamine autoreceptors a hitherto neglected role in the therapeutic effects of oral methylphenidate in attention deficit/hyperactivity disorder. The absence of significant case-control differences in D2/D3 receptor availability (despite the observed relationships between dopamine activity and attention) suggests that dopamine dysregulation per se is unlikely to be the primary cause underlying attention deficit/hyperactivity disorder pathology in adults. This conclusion is reinforced by evidence of neuroanatomical changes in the same set of patients with attention deficit/hyperactivity disorder.

Verbal Working Memory-Related Functional Connectivity Alterations in Boys with Attention-Deficit/hyperactivity Disorder and the Effects of Methylphenidate.

Functional MRI Study of Verbal Working Memory of ADHD Children Before and after Methylphenidate Treatment

Methylphenidate Normalizes Resting-State Brain Dysfunction in Boys With Attention Deficit Hyperactivity Disorder

Effects of methylphenidate on resting-state brain activity in normal adults: an fMRI study

Functional Mri in Attention-Deficit Hyperactivity Disorder: Evidence for Hypofrontality

Functional Near-Infrared Spectroscopy Study on Inhibitory Control Ability of Children with Attention Deficit Hyperactivity Disorder with Methylphenidate Therapy: an Experimental, Longitudinal, and Neuroimaging Study

The effects of methylphenidate on cognitive function in children with attention-deficit/hyperactivity disorder

Effect of methylphenidate on functional controllability: a preliminary study in medication-naïve children with ADHD

The Effects of First-Dose Methylphenidate on the Neural Signatures of Visual Selective Attention in Children with Attention-Deficit/hyperactivity Disorder

Effects of Extended-released Methylphenidate on the Inhibition of Children with Attention Deficit Hyperactivity Disorder

Neural markers of methylphenidate response in children with attention deficit hyperactivity disorder and the impact on executive function

Methylphenidate normalizes aberrant beta oscillations and reduces alpha power during retention in children with ADHD

Shared and Unique Effects of Long-Term Administration of Methylphenidate and Atomoxetine on Degree Centrality in Medication-Naïve Children with Attention-Deficit/Hyperactive Disorder

Functional MRI Study of Verbal Working Memory in Children with Attention Deficit Hyperactivity Disorder

Methylphenidate and atomoxetine normalise fronto-parietal underactivation during sustained attention in ADHD adolescents

Linked Anatomical and Functional Brain Alterations in Children with Attention-Deficit/hyperactivity Disorder

A Positron Emission Tomography Study of Nigro-Striatal Dopaminergic Mechanisms Underlying Attention: Implications for ADHD and Its Treatment.

Linked anatomical and functional brain alterations in children with attention-deficit/hyperactivity disorder.

Voxel-Based Morphometry in Medicated-naive Boys with Attention-deficit/hyperactivity Disorder (ADHD)

Cortical Morphometric Abnormality and Its Association with Working Memory in Children with Attention-Deficit/Hyperactivity Disorder

Effects of Methylphenidate on Default-Mode Network/Task-Positive Network Synchronization in Children With ADHD